Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Mol Cancer Res. 2016 Mar 21;14(6):518–527. doi: 10.1158/1541-7786.MCR-16-0013

Figure 1.

Figure 1

CX3CR1 is expressed in primary and metastatic breast cancer. A, Tissues from the four main subtypes of breast adenocarcinoma: Luminal A (LUM A; 7 specimens), Luminal B (LUM B; 7 specimens), Human Epidermal growth factor Receptor 2 positive (HER2; 7 specimens) and Triple Negative (TN; 8 specimens) stained all positive for CX3CR1 expression. B, Two representative images of a total of seven biopsy specimens of skeletal metastatic tumors that were collected from different breast cancer patients and also stained all positive for CX3CR1. Hematoxylin and Eosin staining is shown in the upper panels. Magnification: 100-200x. Scale bar: 50μm

HHS Vulnerability Disclosure